Redeye reiterates its positive stance on Westpay after well received product launches and good cost control. The COVID-19 pandemic is a substantial challenge and adds uncertainty. However, the company took swift cost lowering measures and implemented short-term work-allowance, while recurring revenue gave stability to the revenue levels. Looking ahead, the operations are picking up pace after the low point in Q2, and we believe changed payment behaviors will benefit Westpay in the long-run.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/